Holen Sie sich die Stockscreener-App
558.32
2.61%
-14.97
Handel nachbörslich:
558.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$573.29
Offen:
$576.535
24-Stunden-Volumen:
445.25K
Relative Volume:
0.91
Marktkapitalisierung:
$44.46B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
42.69
EPS:
13.0798
Netto-Cashflow:
$1.04B
1W Leistung:
-3.28%
1M Leistung:
-14.98%
6M Leistung:
-11.69%
1J Leistung:
+32.13%
1-Tages-Spanne:
$557.35
$576.87
1-Wochen-Bereich:
$557.35
$594.77
52-Wochen-Spanne:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
558.32 | 44.46B | 4.30B | 1.06B | 1.04B | 13.08 |
TMO
Thermo Fisher Scientific Inc
|
473.36 | 175.85B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
181.52 | 128.46B | 24.57B | 3.60B | 5.26B | 5.051 |
A
Agilent Technologies Inc
|
110.24 | 31.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
289.16 | 28.37B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDXX (IDEXX Laboratories) Net Issuance of Preferred Stock : $0 Mil (TTM As of Dec. 2025) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX (NASDAQ: IDXX) proxy details 2025 growth, CEO change and key governance votes - stocktitan.net
Vanguard disaggregates holdings; IDEXX (NASDAQ: IDXX) shows zero - stocktitan.net
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Global X Japan Co. Ltd. - marketbeat.com
Riverbridge Partners LLC Sells 5,734 Shares of IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX Laboratories Announces Executive Departure and $984,000 Separation Agreement with Nimrata Hunt, PhD - Minichart
IDEXX Laboratories (IDXX) Announces Executive Transition with De - GuruFocus
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment - TipRanks
Idexx Laboratories announces executive departure and separation agreement - investing.com
IDEXX: Nimrata Hunt to Leave EVP Role, Will Serve as Advisor Through July 13, 2026 - TradingView
IDEXX Laboratories (NASDAQ: IDXX) executive Nimrata Hunt plans exit with package - stocktitan.net
IDEXX Laboratories Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Nordea Investment Management AB Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - marketbeat.com
5-Star Stocks Poised to Pop: IDEXX Labs - Yahoo
IDXX (IDEXX Laboratories) Earnings Power Value (EPV) : $121.38 (As of Dec25) - GuruFocus
IDEXX Laboratories stock faces institutional shifts and insider sales amid strong FY2026 guidance - AD HOC NEWS
IDXX (IDEXX Laboratories) Cash Flow from Investing : $-136 Mil (TTM As of Dec. 2025) - GuruFocus
Portfolio Recap: Is IDEXX Laboratories Inc showing insider buyingQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Here’s what analysts are saying about IDEXX Laboratories (IDXX) - MSN
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversified Trust Co. - marketbeat.com
Assenagon Asset Management S.A. Acquires 19,741 Shares of IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
UBS reiterates Neutral rating on IDEXX Laboratories stock at $730 By Investing.com - Investing.com Canada
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $730 - 富途牛牛
Seilern Investment Management Ltd Decreases Stake in IDEXX Laboratories, Inc. $IDXX - marketbeat.com
Marshall Financial Group LLC Sells 1,936 Shares of IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co. - marketbeat.com
Procyon Advisors LLC Buys Shares of 2,905 IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX Laboratories stock faces valuation scrutiny amid steady animal health demand on NASDAQ - AD HOC NEWS
Pricier vet care: Fewer visits but still many $11,000 surgeries - Fortune
IDEXX Stock Fell 14% in 2026. Here’s Why $750 Target Mean Still Holds - TIKR.com
Here's why Idexx Laboratories (IDXX) is a strong growth stock - MSN
CIBC Bancorp USA Inc. Invests $8.93 Million in IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX Laboratories Experiences Revision in Stock Evaluation Amid Mixed Technical Signals - Markets Mojo
Swiss Life Asset Management Ltd Has $16.96 Million Holdings in IDEXX Laboratories, Inc. $IDXX - marketbeat.com
Insight Wealth Strategies LLC Sells 1,819 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Mirabella Financial Services LLP Buys 2,683 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Achmea Investment Management B.V. Grows Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Is IDEXX Laboratories, Inc. (IDXX) a good stock to buy? - MSN
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MSN
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Faithward Advisors LLC Purchases Shares of 5,761 IDEXX Laboratories, Inc. - National Today
Faithward Advisors LLC Purchases Shares of 5,761 IDEXX Laboratories, Inc. $IDXX - MarketBeat
Stance Capital LLC Increases Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Dorsey Wright & Associates Invests $2.30 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
CIBC Private Wealth Group LLC Lowers Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Should IDEXX’s Earnings Beat and Higher Guidance Require Action From IDEXX Laboratories (IDXX) Investors? - simplywall.st
Sentiment Watch: Will IDEXX Laboratories Inc outperform the market in YEARWeekly Trend Recap & Expert Curated Trade Ideas - baoquankhu1.vn
Mirabella Financial Services LLP Purchases 2,683 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):